This trial is testing how well stereotactic body radiation therapy works to treat patients with liver cancer.
- Liver Cancer
1 Primary · 7 Secondary · Reporting Duration: Up to time of progression, transplantation, death or 2-years after last SBRT dose, whichever occurs first
Side Effects for
Awards & Highlights
1 Treatment Group
1 of 1
15 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic Body Radiation Therapy · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this investigation enlisting participants presently?
"The official records from clinicaltrials.gov state that this research study is open for participants and has been since February 7th 2019. The trial was most recently amended on September 22nd 2022." - Anonymous Online Contributor
How many test subjects are involved in this experiment?
"Affirmative, according to clinicaltrials.gov this research is actively recruiting eligible participants. It was originally posted on February 7th 2019 and the latest update occurred on September 22nd 2022. For now, they are targeting 15 individuals from a single site." - Anonymous Online Contributor